Dr. Lal Path Labs Ltd. - Asset Resilience Ratio

Latest as of March 2026: 13.43%

Dr. Lal Path Labs Ltd. (LALPATHLAB) has an Asset Resilience Ratio of 13.43% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Dr. Lal Path Labs Ltd.'s equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Rs4.23 Billion

≈ $45.70 Million USD Cash + Short-term Investments

Total Assets

Rs31.46 Billion

≈ $340.23 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2026)

This chart shows how Dr. Lal Path Labs Ltd.'s Asset Resilience Ratio has changed over time. See Dr. Lal Path Labs Ltd. (LALPATHLAB) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Dr. Lal Path Labs Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Dr. Lal Path Labs Ltd..

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs4.23 Billion	13.43%
Total Liquid Assets	Rs4.23 Billion	13.43%

Asset Resilience Insights

Moderate Liquidity: Dr. Lal Path Labs Ltd. has 13.43% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Dr. Lal Path Labs Ltd. Industry Peers by Asset Resilience Ratio

Compare Dr. Lal Path Labs Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fleury S.A. SA:FLRY3	Diagnostics & Research	16.06%
Wuhan Thalys Med Tech Co Ltd SHG:603716	Diagnostics & Research	0.12%
Spectral Med Inc TO:EDT	Diagnostics & Research	11.67%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Genetic Signatures Ltd AU:GSS	Diagnostics & Research	60.91%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Dr. Lal Path Labs Ltd. (2011–2026)

The table below shows the annual Asset Resilience Ratio data for Dr. Lal Path Labs Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	13.43%	Rs4.23 Billion ≈ $45.70 Million	Rs31.46 Billion ≈ $340.23 Million	-28.53pp
2025-03-31	41.96%	Rs11.40 Billion ≈ $123.29 Million	Rs27.17 Billion ≈ $293.81 Million	+4.60pp
2024-03-31	37.37%	Rs9.18 Billion ≈ $99.25 Million	Rs24.56 Billion ≈ $265.60 Million	+2.26pp
2023-03-31	35.11%	Rs8.38 Billion ≈ $90.57 Million	Rs23.86 Billion ≈ $257.98 Million	+7.03pp
2022-03-31	28.08%	Rs6.61 Billion ≈ $71.45 Million	Rs23.53 Billion ≈ $254.49 Million	-29.58pp
2021-03-31	57.66%	Rs9.58 Billion ≈ $103.59 Million	Rs16.61 Billion ≈ $179.67 Million	+5.29pp
2020-03-31	52.37%	Rs7.20 Billion ≈ $77.83 Million	Rs13.74 Billion ≈ $148.63 Million	-7.23pp
2019-03-31	59.60%	Rs6.50 Billion ≈ $70.28 Million	Rs10.90 Billion ≈ $117.93 Million	+7.26pp
2018-03-31	52.34%	Rs4.81 Billion ≈ $52.01 Million	Rs9.19 Billion ≈ $99.37 Million	+7.70pp
2017-03-31	44.65%	Rs3.41 Billion ≈ $36.90 Million	Rs7.64 Billion ≈ $82.64 Million	+0.62pp
2016-03-31	44.03%	Rs2.75 Billion ≈ $29.77 Million	Rs6.25 Billion ≈ $67.62 Million	+9.77pp
2015-03-31	34.26%	Rs1.63 Billion ≈ $17.61 Million	Rs4.75 Billion ≈ $51.40 Million	+6.24pp
2014-03-31	28.02%	Rs984.88 Million ≈ $10.65 Million	Rs3.52 Billion ≈ $38.02 Million	+6.11pp
2013-03-31	21.91%	Rs589.39 Million ≈ $6.37 Million	Rs2.69 Billion ≈ $29.09 Million	+16.13pp
2012-03-31	5.78%	Rs102.37 Million ≈ $1.11 Million	Rs1.77 Billion ≈ $19.15 Million	-5.43pp
2011-03-31	11.21%	Rs190.20 Million ≈ $2.06 Million	Rs1.70 Billion ≈ $18.35 Million	--

pp = percentage points

About Dr. Lal Path Labs Ltd.

NSE:LALPATHLAB India Diagnostics & Research

Market Cap

$3.00 Billion

Rs277.67 Billion INR

Market Cap Rank

#5010 Global

#223 in India

Share Price

Rs1662.90

Change (1 day)

+0.67%

52-Week Range

Rs1307.60 - Rs3473.50

All Time High

Rs4119.53